{
    "code": "52027333",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027333",
    "time": "2021-10-15 04:34:21",
    "許可證字號": "衛部藥輸字第027333號",
    "註銷狀態": "已註銷",
    "註銷日期": "110\/09\/14",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "111\/12\/12",
    "發證日期": "106\/12\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202733308",
    "中文品名": "卓立酸濃縮注射液4毫克\/5毫升",
    "英文品名": "Zoledronic Acid Hospira Concentrate for Solution for Infusion 4mg\/5ml",
    "適應症": "與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。治療惡性腫瘤之高血鈣併發症(HCM)。",
    "劑型": "270注射劑",
    "包裝": "(CZ Resin plastic vial)塑膠小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "ZOLEDRONIC ACID MONOHYDRATE",
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "委託包裝廠(貼標)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001630",
            "成分名稱": "ZOLEDRONIC ACID MONOHYDRATE",
            "含量描述": "(equivalent to Anhydrate....4mg)",
            "含量": "4.2600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "ZDA_Vial_photo_201904-108-04-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=002&Type=10"
        },
        {
            "title": "52027333-107-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Zoledronic Acid Hospira 4 mg per 5 ml LLD MOH 20161108-2-108-04-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=002&Type=9"
        },
        {
            "title": "Zoledronic Acid Hospira LLD MOH 20161108-1-107-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=001&Type=9"
        },
        {
            "title": "ZDA_AW_photo_201904-108-04-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=004&Type=8"
        },
        {
            "title": "Zoledronic Acid Hospira 4 mg per 5 ml 外盒-107-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=003&Type=8"
        },
        {
            "title": "Zoledronic Acid Hospira 4 mg per 5 ml 小瓶標籤-107-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=002&Type=8"
        },
        {
            "title": "Zoledronic Acd Hospira 4 mg per 5 ml 中文小標籤-107-01-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027333&Seq=001&Type=8"
        }
    ]
}